Laboratory research record on Cagrilintide [PMID: 42251858] PubMed laboratory record discussing Cagrilintide in a research context
A person with lupus might be more likely to benefit from discussing a GLP-1 medicine with their clinician if they have: Type 2 diabetes Obesity or overweight with weight-related health problems High blood pressure High cholesterol Fatty liver disease High cardiovascular risk Kidney risk factors Difficulty losing weight despite serious lifestyle efforts These medicines may be especially worth discussing when weight, diabetes, or cardiovascular risk is making lupus care more difficult
Check out our website for more information
Once approved, your medication will be shipped with free 2-day delivery, and you'll have access to continuous clinical support throughout your treatment journey
Whether finding care for the first time or transitioning from another provider, Klinic offers a stress-free path to weight management
[1] Whilst Ozempic has demonstrated significant benefits in glycaemic control and cardiovascular outcomes in clinical trials such as SUSTAIN-6, patients occasionally raise concerns about potential effects on sexual function, including erectile dysfunction (ED)